Winston A - Search Results

1

High rates of asymptomatic neurocognitive impairment in vertically acquired HIV-1-infected adolescents surviving to adulthood.

Paramesparan Y, Garvey LJ, Ashby J, Foster CJ, Fidler S, Winston A. Paramesparan Y, et al. Among authors: winston a. J Acquir Immune Defic Syndr. 2010 Sep;55(1):134-6. doi: 10.1097/QAI.0b013e3181d90e8c. J Acquir Immune Defic Syndr. 2010. PMID: 20733406 No abstract available.

2

Response to "Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment".

Garvey L, Thomson EC, Main J, Winston A. Garvey L, et al. Among authors: winston a. J Acquir Immune Defic Syndr. 2007 Dec 15;46(5):656-7, author reply 657-8. doi: 10.1097/QAI.0b013e318157b0c8. J Acquir Immune Defic Syndr. 2007. PMID: 18043322 No abstract available.

3

Rilpivirine: a novel non-nucleoside reverse transcriptase inhibitor.

Garvey L, Winston A. Garvey L, et al. Among authors: winston a. Expert Opin Investig Drugs. 2009 Jul;18(7):1035-41. doi: 10.1517/13543780903055056. Expert Opin Investig Drugs. 2009. PMID: 19548857 Review.

4

Detectable cerebrospinal fluid HIV RNA with associated neurological deficits, despite suppression of HIV replication in the plasma compartment.

Garvey LJ, Everitt A, Winston A, Mackie NE, Benzie A. Garvey LJ, et al. Among authors: winston a. AIDS. 2009 Jul 17;23(11):1443-4. doi: 10.1097/QAD.0b013e32832d077c. AIDS. 2009. PMID: 19564723 No abstract available.

5

Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy.

Garvey LJ, Yerrakalva D, Winston A. Garvey LJ, et al. Among authors: winston a. AIDS Res Hum Retroviruses. 2009 Aug;25(8):765-9. doi: 10.1089/aid.2008.0292. AIDS Res Hum Retroviruses. 2009. PMID: 19678764

6

The effects of a nucleoside-sparing antiretroviral regimen on the pharmacokinetics of ritonavir-boosted darunavir in HIV type-1-infected patients.

Garvey L, Latch N, Erlwein OW, Mackie NE, Walsh J, Scullard G, McClure MO, Dickinson L, Back D, Winston A. Garvey L, et al. Among authors: winston a. Antivir Ther. 2010;15(2):213-8. doi: 10.3851/IMP1517. Antivir Ther. 2010. PMID: 20386076 Clinical Trial.

7

A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine.

Waters L, Fisher M, Winston A, Higgs C, Hadley W, Garvey L, Mandalia S, Perry N, Nicola M, Nelson M. Waters L, et al. Among authors: winston a. AIDS. 2011 Jan 2;25(1):65-71. doi: 10.1097/QAD.0b013e328341685b. AIDS. 2011. PMID: 21099666 Clinical Trial.

8

Changes in cerebral function parameters in HIV type 1-infected subjects switching to darunavir/ritonavir either as monotherapy or with nucleoside analogues.

Garvey L, Higgs C, Mohammed P, Hill A, Allsop JM, Taylor-Robinson SD, Nelson M, Winston A. Garvey L, et al. Among authors: winston a. AIDS Res Hum Retroviruses. 2011 Jul;27(7):701-3. doi: 10.1089/AID.2010.0290. Epub 2011 Jan 8. AIDS Res Hum Retroviruses. 2011. PMID: 21128867 No abstract available.

9

HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era.

UK Collaborative HIV Cohort (CHIC) Study Steering Committee; Garvey L, Winston A, Walsh J, Post F, Porter K, Gazzard B, Fisher M, Leen C, Pillay D, Hill T, Johnson M, Gilson R, Anderson J, Easterbrook P, Bansi L, Orkin C, Ainsworth J, Phillips AN, Sabin CA. UK Collaborative HIV Cohort (CHIC) Study Steering Committee, et al. Among authors: winston a. Eur J Neurol. 2011 Mar;18(3):527-34. doi: 10.1111/j.1468-1331.2010.03291.x. Epub 2010 Dec 15. Eur J Neurol. 2011. PMID: 21159073

10

Superior neurocognitive function is associated with central nervous system antiretroviral drug penetration only in regimens containing more than three antiretroviral agents.

Winston A, Garvey L, Sabin CA. Winston A, et al. AIDS. 2011 Apr 24;25(7):1014-5. doi: 10.1097/QAD.0b013e3283454c74. AIDS. 2011. PMID: 21487256 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

494 results

Search Page

Filters